Cargando…
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
SIMPLE SUMMARY: Epithelial ovarian cancer (EOC) is a heterogenous disease and new combination therapies are employed to improve treatment, decrease disease recurrence, and avoid the development of treatment resistance. Immunotherapy has been suggested to boost the immune system and improve the progn...
Autores principales: | Kleinmanns, Katrin, Gullaksen, Stein-Erik, Bredholt, Geir, Davidson, Ben, Torkildsen, Cecilie Fredvik, Grindheim, Sindre, Bjørge, Line, McCormack, Emmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265069/ https://www.ncbi.nlm.nih.gov/pubmed/35804867 http://dx.doi.org/10.3390/cancers14133092 |
Ejemplares similares
-
Phenotypic Characterization by Mass Cytometry of the Microenvironment in Ovarian Cancer and Impact of Tumor Dissociation Methods
por: Anandan, Shamundeeswari, et al.
Publicado: (2021) -
Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study
por: Thomsen, Liv Cecilie Vestrheim, et al.
Publicado: (2023) -
The Emerging Role of CD24 in Cancer Theranostics—A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
CD24-targeted intraoperative fluorescence image-guided surgery leads to improved cytoreduction of ovarian cancer in a preclinical orthotopic surgical model
por: Kleinmanns, Katrin, et al.
Publicado: (2020) -
Comparison of Five Near-Infrared Fluorescent Folate Conjugates in an Ovarian Cancer Model
por: García de Jalón, Elvira, et al.
Publicado: (2021)